Record-Breaking Price Movement
On 18 Feb 2026, Acutaas Chemicals Ltd’s stock price closed just 0.95% shy of its 52-week high of ₹2,120, marking a new peak in its trading history. The stock outperformed its sector by 0.98% on the day, registering a gain of 1.99% compared to the Sensex’s decline of 0.27%. This marks the third consecutive day of gains, with a cumulative return of 4.15% over this period, signalling strong momentum.
The stock is currently trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a sustained upward trend and positive investor sentiment.
Exceptional Long-Term Returns
Acutaas Chemicals Ltd has delivered remarkable returns over multiple time horizons. Over the past year, the stock has surged by 93.26%, vastly outperforming the Sensex’s 9.55% gain. Year-to-date performance stands at 24.23%, while the Sensex has declined by 2.34% in the same period. Over three years, the stock has generated an extraordinary 357.51% return, compared to the Sensex’s 36.43% rise, placing Acutaas Chemicals among the top performers in its category.
These figures highlight the company’s ability to consistently outperform broader market indices and its sector peers, reflecting strong operational execution and investor confidence.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
Strong Financial Metrics Underpinning Growth
Acutaas Chemicals Ltd’s financial health remains robust, supported by a zero average Debt to Equity ratio, underscoring a debt-free capital structure. The company has demonstrated healthy long-term growth with net sales expanding at an annual rate of 26.84%, while operating profit has increased by 38.56% annually.
Net profit growth has been particularly impressive, rising by 47.82%, with the company declaring outstanding results in December 2025. This marks six consecutive quarters of positive results, reflecting consistent operational strength and profitability.
Efficiency and Return Ratios
Return on Capital Employed (ROCE) for the half-year period stands at a high 21.30%, indicating efficient utilisation of capital. Inventory turnover ratio is also strong at 5.74 times, demonstrating effective inventory management. Additionally, the debtors turnover ratio is 3.76 times, reflecting efficient collection processes and healthy cash flow management.
Institutional Confidence and Market Recognition
Institutional investors hold a significant 38.38% stake in Acutaas Chemicals Ltd, signalling confidence from well-resourced market participants with deep fundamental analysis capabilities. The company ranks among the top 1% of all 4,000 stocks rated by MarketsMojo, with a Mojo Score of 82.0 and a Mojo Grade upgraded to Strong Buy from Buy on 6 Oct 2025.
Within the small-cap universe, Acutaas Chemicals is ranked 4th, and it holds the 16th position across the entire market, reflecting its strong standing and market reputation.
Market-Beating Performance Across Timeframes
The company’s stock has consistently outperformed the BSE500 index over the last three years, one year, and three months, delivering superior returns to investors. This sustained outperformance is a testament to the company’s strong fundamentals and effective business strategies.
Get the full story on Acutaas Chemicals Ltd! Our detailed research dives into fundamentals, sector comparison, technical analysis, and valuations for this Pharmaceuticals & Biotechnology small-cap. Make informed decisions!
- - Full research story
- - Sector comparison done
- - Informed decision support
Valuation and Profitability Considerations
Despite its strong growth, Acutaas Chemicals Ltd carries a premium valuation. The company’s Return on Equity (ROE) stands at 15.8%, with a Price to Book Value ratio of 12.1, indicating a very expensive valuation relative to peers. The stock trades at a premium compared to the average historical valuations of its sector counterparts.
Over the past year, profits have risen by 136%, outpacing the stock’s 93.26% return, resulting in a PEG ratio of 0.4. This suggests that the company’s earnings growth is strong relative to its price appreciation, a factor that investors may consider when analysing valuation metrics.
Summary of Acutaas Chemicals Ltd’s Market Milestone
Acutaas Chemicals Ltd’s achievement of an all-time high stock price is a reflection of its sustained financial strength, operational efficiency, and market recognition. The company’s impressive growth rates in sales, profits, and returns, combined with strong institutional backing and a debt-free balance sheet, have propelled it to this significant milestone.
While the valuation remains on the higher side, the company’s consistent delivery of positive results and market-beating returns over multiple timeframes underscore its position as a leading player in the Pharmaceuticals & Biotechnology sector.
Only Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Start Today
